No abstract available
MeSH terms
-
Blood Platelets / drug effects
-
Blood Platelets / enzymology
-
Blood Platelets / pathology
-
Europe / epidemiology
-
Gene Expression
-
Health Services Needs and Demand / trends*
-
Humans
-
Janus Kinase 2 / antagonists & inhibitors
-
Janus Kinase 2 / genetics
-
Janus Kinase 2 / metabolism
-
Nitriles
-
Physicians
-
Prevalence
-
Primary Myelofibrosis / diagnosis
-
Primary Myelofibrosis / drug therapy
-
Primary Myelofibrosis / epidemiology*
-
Primary Myelofibrosis / pathology
-
Pyrazoles / therapeutic use*
-
Pyrimidines
-
Pyrrolidines / therapeutic use*
-
Severity of Illness Index
-
Sulfonamides / therapeutic use*
-
Surveys and Questionnaires
-
Thrombocytopenia / diagnosis
-
Thrombocytopenia / drug therapy
-
Thrombocytopenia / epidemiology*
-
Thrombocytopenia / pathology
-
United States / epidemiology
Substances
-
Nitriles
-
Pyrazoles
-
Pyrimidines
-
Pyrrolidines
-
Sulfonamides
-
fedratinib
-
ruxolitinib
-
JAK2 protein, human
-
Janus Kinase 2